Mass Torts

Strategic Comparison: Uber MDL vs Lyft, JUUL, Roundup, and the Boy Scouts/Catholic Church Precedent

MDL 3084 is not the first mass tort of its scale, and the comparables matter. Lyft is the parallel-defendant model. JUUL is the procedural blueprint. Roundup is the punitive-damages cautionary tale. The institutional-survivor cases are the adult-revival template. This is the business-of-law read on where MDL 3084 lands across all four, with per-case economics, framework timing, and firm-investment math.

Strategic Comparison: Uber MDL vs Lyft, JUUL, Roundup, and the Boy Scouts/Catholic Church Precedent

MDL 3084 is the first rideshare-platform sexual-assault MDL to reach bellwether trial, but it is not the first mass-tort of its scale or structure. Four reference dockets — the Lyft sexual-assault MDL, the JUUL e-cigarette MDL, the Roundup glyphosate litigation, and the Boy Scouts / Catholic Church bankruptcy-driven survivor resolutions — set the precedent that MDL 3084 will most plausibly follow. Each tells a different part of the story: Lyft for the parallel-defendant comparison, JUUL for the consumer-product corporate-conduct theory, Roundup for the punitive-damages trajectory, and the institutional-survivor cases for the adult-revival-window framework.

This article is for the business-of-law reader: managing partners deciding whether to allocate firm resources to MDL 3084, finance teams modeling case-pipeline economics, and plaintiff steering committees calibrating settlement-framework expectations against historical comparables.

Lyft MDL — the closest parallel

Lyft's sexual-assault MDL (MDL No. 2956, In re Lyft Driver Sexual Assault Litigation, also pending in the Northern District of California) is the closest factual parallel to MDL 3084. The Lyft MDL was consolidated in 2020 with approximately 1,300 cases at its peak. Bellwether trials began in 2023; the first major plaintiff verdict was the 2024 Vivian v. Lyft trial, returning approximately $20 million in compensatory damages.

Lyft's docket is materially smaller than Uber's — roughly one-third the case count — which reflects market share rather than a different underlying assault rate. The Lyft MDL has moved more slowly than the Uber MDL in part because plaintiff firms initially concentrated resources on Uber. The Lyft case-management orders draw heavily from MDL 3084's procedural framework, but the substantive law issues (non-delegable duty, common-carrier doctrine, Rule 404(b) admission of internal safety reports) have been litigated more aggressively in Uber's docket and now apply to both.

Lyft has not yet entered global-settlement framework negotiation. Industry expectation is that Lyft's framework will follow Uber's by 12-18 months, scaled by case count. If Uber's framework values cases at an average $700,000 net to plaintiff (consistent with the projections in the settlement framework analysis), Lyft's framework would plausibly land at $400-700K average — a smaller total pool but similar per-case math.

The strategic implication: plaintiff firms with Uber MDL infrastructure can extend the same intake, evidence, and settlement-framework expertise to Lyft cases with marginal additional investment. The two MDLs effectively constitute a single practice area for plaintiff-side firms; defense-side, the two corporate defendants are coordinating discovery posture more than the public docket reveals.

JUUL — the consumer-product mass-tort blueprint

The JUUL MDL (MDL No. 2913, In re JUUL Labs, Inc., Marketing, Sales Practices, and Products Liability Litigation) is not factually parallel to MDL 3084 — the underlying harm is nicotine addiction and adolescent health harm rather than sexual assault — but it is the procedural blueprint for consumer-product corporate-conduct litigation.

JUUL's MDL consolidated approximately 4,500 cases plus thousands of state-court parallel cases. The settlement framework, announced in 2022 at approximately $1.7 billion globally across personal-injury and government claims, used a tier matrix with documented-harm adjustments. JUUL's framework is the template that MDL 3084's PSC is most plausibly studying for tier structure.

Two lessons from JUUL apply to MDL 3084. First, the framework took roughly four years from MDL consolidation to global settlement announcement; MDL 3084 was consolidated in October 2023, suggesting framework negotiation in 2027 if it follows JUUL's timeline. Second, JUUL's framework included substantial common-benefit assessment (approximately 10%) and Medicare/Medicaid lien resolution at favorable global terms — features that MDL 3084's framework is expected to replicate.

The JUUL framework also included an opt-out provision used by approximately 8% of plaintiffs. Opt-out plaintiffs proceeded individually; most settled in the year after the framework at terms broadly similar to the framework tier they would have received. The opt-out rate is a useful planning anchor for MDL 3084 — roughly one in 12 plaintiffs will opt out, and plaintiff firms should plan continued individual-case capacity at that rate.

Roundup — the punitive-damages trajectory

The Roundup glyphosate litigation (multiple state and federal proceedings, primarily MDL 2741) is the comparable for corporate-conduct + punitive damages. The headline numbers are large: Bayer's $11 billion global settlement framework announced in 2020, followed by continued individual trials and supplementary settlements. Total Bayer exposure now exceeds $16 billion.

For MDL 3084, the Roundup-relevant lesson is the punitive-damages trajectory. Early Roundup bellwether verdicts included substantial punitive components (the Johnson, Hardeman, and Pilliod verdicts each included nine-figure punitive awards). The punitive trajectory was the leverage that brought Bayer to the framework table. Uber's first bellwether bifurcated punitives and the parties settled the punitive phase; this approach preserves Uber's appellate flexibility but also leaves the punitive question unanswered for the docket.

If a September 2026 bellwether includes a punitive phase that proceeds to verdict, and the jury returns nine-figure punitives, the MDL 3084 settlement framework valuation moves substantially upward. Conversely, if Uber successfully bifurcates and settles punitives in every bellwether, the docket's compensatory-only valuation will be lower than it otherwise would. The punitive question is the wild card.

Roundup also illustrates the long tail of mass-tort litigation. Bayer's framework was announced in 2020; individual trials and settlements continue in 2026. Plaintiff firms with strong individual cases can sometimes do better outside the framework than inside it, particularly for cases with strong punitive theory. The trade-off is time and trial risk.

Boy Scouts and Catholic Church — the adult-survivor template

The Boy Scouts of America bankruptcy plan ($2.46 billion across approximately 82,000 abuse claims) and the various Catholic Church diocesan bankruptcies (cumulative liability exceeding $5 billion across multiple proceedings) constitute the closest template for adult-survivor mass-resolution outside of bankruptcy. Both used a tier-matrix approach, both involved revival-window legislation as the volume driver, and both produced average per-claim recoveries in the $20,000-$100,000 range — substantially lower than what MDL 3084 is expected to produce.

The per-claim recovery gap matters. Boy Scouts and Catholic Church cases generated lower average recovery because (a) the defendant entities had limited assets relative to claim count, forcing bankruptcy-driven pro rata distribution rather than negotiated per-case settlement, (b) institutional plaintiffs' counsel coordinated aggressively to maximize claim count, diluting per-case value, and (c) the conduct timeline extended back decades, producing weaker corroboration on individual cases.

MDL 3084 should produce substantially higher per-case recovery than these institutional comparables. Uber's market capitalization (approximately $180 billion as of May 2026) gives the defendant the capacity to pay framework-level recovery without bankruptcy. The conduct timeline is shorter — most relevant rides occurred in the last 8-10 years — producing stronger corroboration. Plaintiffs' counsel is less concentrated than in the institutional cases, which has so far reduced the dilution dynamic.

The Boy Scouts and Catholic Church template is most directly relevant for the revival-window dynamic. Both proceedings benefited enormously from state-level revival legislation that opened windows for older claims. AB 2777 plays a similar role for MDL 3084. The institutional cases also produced sophisticated trauma-informed claim evaluation processes that MDL 3084 is now drawing on for tier-matrix damages assessment.

Where MDL 3084 lands relative to these comparables

Synthesizing across the four reference dockets, MDL 3084's most plausible settlement framework profile is:

  • Total pool: $3-5 billion across approximately 4,000-5,000 claims (current docket plus expected additional filings through 2027 framework deadline). Pool is higher than JUUL's $1.7 billion because of higher per-case severity; lower than Roundup's $11 billion because of fewer claims and capped punitive exposure.
  • Per-case average: $700,000 gross / $400,000 net to plaintiff at framework conclusion. Substantially higher than Boy Scouts / Catholic Church averages; comparable to upper-tier JUUL settlements; lower than Roundup individual-trial outcomes.
  • Timing: Framework negotiation in early-to-mid 2027; framework completion 2028; long-tail individual cases and appeals through 2030. Roughly the JUUL timeline scaled for the slightly larger docket.
  • Opt-out rate: 8-12% based on JUUL precedent. Plaintiff firms should maintain individual-case infrastructure at that rate.
  • Common-benefit assessment: 8-10% based on JUUL and Roundup precedent.
  • Lien resolution: PSC-negotiated global resolution with CMS and major Medicaid systems, parallel to JUUL framework. ERISA lien resolution remains case-by-case but improved by aggregate posture.

Strategic implications for plaintiff firms

For plaintiff firms evaluating MDL 3084 practice investment, three points matter.

First, the per-case economics support substantial firm investment. At $400,000 net-to-plaintiff and a 40% contingency fee, gross attorney revenue per case is approximately $300,000-$600,000 depending on settlement tier. A firm handling 50-100 cases in MDL 3084 plus parallel Lyft cases produces significant aggregate revenue against a per-case cost base of perhaps $15,000-$25,000 in pre-settlement expenses.

Second, the practice infrastructure transfers. Firms with Uber MDL intake systems can apply them to Lyft, to any future rideshare MDL, and to parallel ground-transportation and hospitality industry sexual-assault litigation. The infrastructure investment amortizes across a longer practice horizon than a single MDL.

Third, the opportunity window is closing. AB 2777's revival window expires December 31, 2026. Cases that depend on revival must be filed before that deadline. Firms that invest in MDL 3084 intake infrastructure in the second half of 2026 capture the bulk of the revival-window-dependent cases; firms entering in 2027 or later face a substantially smaller addressable docket.

Strategic implications for Uber

For Uber, the comparables suggest a framework settlement is the dominant strategy. Continued bellwether litigation against well-resourced plaintiff firms with strong corporate-conduct evidence is unlikely to improve Uber's posture; the first two bellwethers established the floor (liability) without establishing a ceiling (damages), and additional bellwethers risk a Roundup-style punitive trajectory.

Uber's most likely path is framework negotiation in 2027 with a total pool sized to remove tail risk. The pool size will be priced relative to the September 2026 bellwether verdicts: a strong plaintiff outcome pushes the pool to the upper end of the $3-5 billion range; a defense-favorable outcome reduces it. Either way, framework completion in 2027-2028 is the expected exit.

The publisher's read

MDL 3084 will most plausibly resemble JUUL more than Roundup — a sizable framework settlement reached within four years of MDL consolidation, with tier-matrix per-case valuation in the seven-figure range, opt-out rates in the 8-12% band, and a multi-year individual-case tail. The defining variable is the punitive-damages trajectory: if the September bellwethers produce significant punitives, valuation pushes upward toward Roundup territory. If Uber successfully bifurcates punitives across the bellwether sequence, valuation stays in JUUL territory.

For the business-of-law reader: this is a major MDL with major investment economics, and it sits at the leading edge of a new mass-tort practice area (rideshare-platform sexual-assault). Firms that build infrastructure here are positioned for a 10-year practice horizon across Uber, Lyft, and any future entrants. The window for new firm entry is approximately the next 12-18 months.

See also: MDL 3084 Hub Overview | Settlement Framework and Medical Liens | Bellwether Trial Tracker | Laws Affecting PI Rideshare Cases

The LawyersTrend Brief · Fridays

One weekly email. Every new article.

Friday mornings — every PI article we publish that week, plus rankings updates and key verdicts. Free. One-click unsubscribe.